The size of the Latin America Varicose Vein Treatment Market was worth USD 35.09 million in 2022 and is forecasted to be growing at a CAGR of 6.7%, to reach USD 48.53 million by 2027.
The rising cases of varicose veins mainly drive the varicose vein treatment market. This condition of enlarged veins appears mostly in feet and legs. It can be caused by pregnancy, hormonal changes, genetic disorders, and high blood pressure.
The market is driven by factors like increasing patient compliance and reliability, growth in healthcare expenditure, rapid growth in the geriatric population, the availability of advanced varicose vein treatment devices, and the huge burden of varicose vein cases. However, the dearth of trained vascular surgeons and the high cost of varicose vein treatment procedures can hinder the growth of this market.
This research report segmented and sub-segmented the Latin American Varicose Vein Treatment Market into the following categories.
By Treatment Types:
Key market participants dominating the Latin American Varicose Vein Treatment Market profiled in the report are Medtronic plc (Ireland), AngioDynamics, Inc. (U.S.), biolitec AG (Austria), Syneron Medical Ltd. (Israel), Lumenis Ltd. (Israel), Dornier MedTech GmbH (Germany), Energist Group (U.K.), Eufoton s.r.l. (Italy), Vascular Solutions, Inc. (U.S.), Quanta System S.p.A. (Italy), Sciton, Inc. (U.S.), Fotona d.o.o. (Slovenia), BTG plc (U.K.), Merz Aesthetics (U.S.).
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org